IOL Insertion/Toric IOLs

Good Outcomes Obtained with New Posterior Chamber Phakic Intraocular Lens

Posted on

Compared to other phakic intraocular lenses (IOLs) for correcting high myopia, a new posterior chamber phakic IOL (IPCL) shows good outcomes at 3 years and may be an effective alternative to current IOLs, according to a prospective, observational case series involving 30 eyes.

Participants underwent implantation of the IPCL for high myopia (> -8.00 diopters [D]). Measurements were taken 3 years later. Among the results:

  • The mean spherical equivalent decreased from -16.5 to -0.89 D.
  • The mean uncorrected and corrected distance visual acuities (UDVA and CDVA) were 0.38 and 0.24 logMAR, respectively.
  • None of the eyes lost any lines and half of eyes gained ≥1 line of CDVA.
  • Adverse events included anterior subcapsular cataract (1 case that did not require surgery) and mild transient increase in intraocular pressure (2 cases, both of which required brief topical medication).
  • 10% of endothelial cells were lost.
  • The IPCL vault decreased over the study from a mean of 626.66 μm at 1 month to 540.22 μm at 3 years.
  • No vision-threatening complications occurred.

Vasavada V, Srivastava S, Vasavada SA, Sudhalkar A, Vasavada AR, Vasavada VA. Safety and Efficacy of a New Phakic Posterior Chamber IOL for Correction of Myopia: 3 Years of Follow-up. J Refract Surg. 2018;34(12):817-823. doi: 10.3928/1081597X-20181105-01.

Related Articles
FDA approves next-generation presbyopia-correcting IOLs
May 11, 2021
New IOL technology in 2020
Nov 15, 2020
Sutureless Flanged IOL Fixation May be Efficient Alternative to Conventional Treatment for IOL Dislocation
Apr 08, 2020
Click to access the login or register cheese